HomeInsightsResults

Bliss Gvs Pharma Ltd Quarterly Result

Bliss Gvs Pharma Ltd Quarterly Result

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

48.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Net Profit

₹ 25.69

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Bliss GVS Pharma Ltd for the Sep '24 is ₹ 222.72 crore as compare to the Jun '24 revenue of ₹ 187.77 crore. This represent the growth of 18.613195%.
  • The ebitda of Bliss GVS Pharma Ltd for the Sep '24 is ₹ 46.51 crore as compare to the Jun '24 ebitda of ₹ 38.45 crore. This represent the growth of 20.962282%.
  • The net profit of Bliss GVS Pharma Ltd for the Sep '24 is ₹ 25.69 crore as compare to the Jun '24 net profit of ₹ 22.11 crore. This represent the growth of 16.191769%.

Results Analysis

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024131.5
21 Nov 2024129
19 Nov 2024120.75
18 Nov 2024121.65
14 Nov 2024117.95
13 Nov 2024116.35
12 Nov 2024118.7
11 Nov 2024121.2
08 Nov 2024124.15
07 Nov 2024126.55

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 202410:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 202418:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 202411:35

News

Bliss GVS Pharma to convene AGM

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...

Read more

04 May 202416:04

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

03 May 202410:36

News

Bliss GVS Pharma announces board meeting date

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...

Read more

26 Apr 202411:02

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Bliss Gvs Pharma Ltd Quarterly Result

What is the EPS of Bliss GVS Pharma Ltd stock?

The Earnings Per Share (EPS) of Bliss GVS Pharma Ltd is 7.99. An EPS is the amount of net income attributed to each share of a common stock.

How is Bliss GVS Pharma Ltd EPS calculated?

The EPS of Bliss GVS Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bliss GVS Pharma Ltd report its EPS?

Bliss GVS Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bliss GVS Pharma Ltd EPS?

Factors that influence the EPS of Bliss GVS Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bliss GVS Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Bliss GVS Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*